Form 4: Orthofix CLO Sells Shares for Tax Obligations

Orthofix Medical Inc.'s Chief Legal Officer, Jorge Andres Cedron, sold common stock to cover tax withholding obligations related to restricted stock unit settlements.

Summary

• Jorge Andres Cedron, Chief Legal Officer (CLO) of Orthofix Medical Inc. (OFIX), reported sales of common stock.
• The sales were made to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
• These transactions were non-discretionary, executed pursuant to a pre-existing sell-to-cover requirement approved and mandated by the Compensation and Talent Development Committee.
• On March 4, 2026, 1,405 shares were sold at a weighted average price of $12.9163 per share, with prices ranging from $12.80 to $13.03.
• On March 5, 2026, 1,370 shares were sold at a weighted average price of $12.5508 per share, with prices ranging from $12.48 to $12.72.
• Following these reported transactions, Cedron beneficially owns 62,749 shares of common stock, which includes 53,902 previously reported restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were non-discretionary and solely for tax withholding purposes related to equity compensation, not a reflection of management's confidence in the company's future.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are a common practice for executives to manage tax liabilities arising from equity compensation, and typically do not signal a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine, non-discretionary sales for tax purposes, not indicative of a change in insider sentiment regarding the company's performance.

Key Dates

Recommendation

The reported transactions are routine, non-discretionary sales by an insider to cover tax obligations associated with restricted stock unit settlements. Such sales do not typically reflect a change in the insider's view of the company's fundamentals or future prospects. Therefore, this filing alone does not provide a basis for a change in investment recommendation, warranting a 'hold' position for existing investors.

Keywords

Orthofix Medical Inc., OFIX, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Corporate Officer, Jorge Andres Cedron